Browsing NTNU Open by Author "Inge Christoffer, Olsen"
Now showing items 1-2 of 2
-
The Labor Progression Study: The use of oxytocin augmentation during labor following Zhang's guideline and the WHO partograph in a cluster randomized trial
Dalbye, Inger Sofie Rebecka; Bernitz, Stine; Inge Christoffer, Olsen; Zhang, Jun; Eggebø, Torbjørn Moe; Rozsa, Daniella Judit; Frøslie, Kathrine Frey; Øian, Pål; Blix, Ellen (Peer reviewed; Journal article, 2019)Introduction - This study aims to investigate the use of oxytocin augmentation during labor in nulliparous women following Zhang's guideline or the WHO partograph. Material and methods - This is a secondary analysis of a ... -
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
Jørgensen, Kristin Kaasen; Inge Christoffer, Olsen; Goll, Guro Løvik; Lorentzen, Merete; Bolstad, Nils; Haavardsholm, Espen A.; Lundin, Knut Erik Aslaksen; Mørk, Cato; Jahnsen, Jørgen; Kvien, Tore Kristian (Journal article; Peer reviewed, 2017)Background TNF inhibitors have improved treatment of Crohn's disease, ulcerative colitis, spondyloarthritis, rheumatoid arthritis, psoriatic arthritis, and chronic plaque psoriasis, but are expensive therapies. The aim ...